HUM vs OCUL · P/E 39, rev $117.76B vs rev $63.7M
Humana Inc (HUM) versus Ocular Therapeutix Inc (OCUL) — a side-by-side from cached financials, not a winner call.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
Ocular Therapeutix Inc (OCUL) is a biotechnology company listed on US.
Latest reported HUM revenue for 2024-12-31 was $117.76B. Net income was $1.21B. Revenue was up 10.7% from 2023-12-31 to 2024-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
Latest reported OCUL revenue for 2024-12-31 was $63.7M. Net income was -$193.5M. Revenue was up 9.0% from 2023-12-31 to 2024-12-31. OCUL currently screens at market cap $1.76B.
HUM currently screens at market cap $43.46B and trailing P/E 38.6. OCUL currently screens at market cap $1.76B.
Not investment advice. Open the HUM and OCUL stock pages for the full models.
Not investment advice.